No evidence for close genetic linkage between a postulated locus for hypertrophic cardiomyopathy and the major histocompatibility complex (antigens HLA-A, HLA-B, and HLA-DR) was found.
Accepted for publication 22 July 1985 pattern of autosomal dominant inheritance of hypertrophic cardiomyopathy in only 30 of 70 families. 8 Maron et al also proposed that the wide range of phenotypic expressions observed may be due to genetic as well as to non-genetic causes. Genetic studies on hypertrophic cardiomyopathy have generally been carried out on rather small families, or on different families grouped together. In the present study we report the clinical, echocardiographic, and HLA findings in a large family through four generations. We studied the spectrum of phenotypic manifestations of a postulated single hypertrophic cardiomyopathy gene inherited as an autosomal dominant trait in this family. We also studied whether hypertrophic cardiomyopathy cosegregated with a particular HLA haplotype in this family. In that case, this HLA haplotype could be a presymptomatic predictor of the disease and might enable early medical intervention.
Patients and methods
The family studied consisted of four generations 168 Familial hypertrophic cardiomyopathy comprising a total of 71 members (Fig. 1 ). Physical and echocardiographic examinations were performed on all except two family members (III-6, III-8). In addition, a 12 lead electrocardiogram and chest x ray films were taken on members of generations I, II, and III. M mode and cross sectional echocardiography were performed with an IREX III, phased array, ultrasonic scanner with a 2-4 MHz handheld transducer. M mode echocardiograms were recorded by means of a heat processed black and white strip chart recorder at a paper speed of 50 mm/s. The cross sectional echocardiographic examinations of the youngest individuals were performed with a Toshiba SAL 50 linear array ultrasonic scanner with a 5 MHz transducer. The thickness of the ventricular wall was measured from the leading edges of the echoes with the transducer being held perpendicular to the chest wall in the 169 standard position.9 The diagnostic criterion of hypertrophic cardiomyopathy or asymmetric septal hypertrophy in adults was increased thickness of the interventricular septum with a septum:posterior left ventricular wall ratio > 1-4 in the absence of cardiac or systemic disease capable of producing left ventricular hypertrophy. A septum:posterior left ventricular wall ratio equal to 1X4 was regarded as normal in individuals aged > 20 years, but as indicating hypertrophic cardiomyopathy in individuals aged < 20 years. In children the criterion of abnormal septal thickness was a measurement exceeding the age specific 95% confidence interval.'0
The HLA antigens were determined by lymphocytotoxicity tests as previously described, " with highly selected antisera defining 13 
GENERATION II
The proband (I-2) has had 14 children of whom seven had died by the time this investigation was started. One (II-5) was stillborn, and two died when very young; II-6 had a fatal accident, and II-15 died from pneumonia. Two brothers (II-1 and II-2) died suddenly at the ages of 22 and 11 years. They had had no symptoms of severe disease. II-3 was II-20 had a four year history of angina pectoris when he was admitted to hospital at the age of 37 years. He had an apical systolic murmur grade 4/6 and echocardiography showed systolic anterior movement of the mitral valve and thickening of the interventricular septum (Fig. 3) . Haemodynamic studies showed a peak left ventricular outflow gradient in systole of 43 mm Hg which was reduced to 15 mm Hg after 4 mg of intravenous propranolol. He has since been treated with oral propranolol. had no symptoms of heart disease at the time of this investigation. Examination of the heart showed a systolic murmur grade 2/6. The electrocardiogram had abnormal Q waves in the inferior leads, T wave inversion in precordial leads, and evidence of right bundle branch block. The echocardiogram showed thickening of the interventricular septum (14mm), and the septum:posterior left ventricular wall ratio was 1-8. There was no systolic anterior movement of the mitral valve and the increased septal thickness was most pronounced in the apical region. No toms of coronary heart disease. The youngest brother (II-22) had no symptoms of heart disease at the time of this study but the electrocardiogram was abnormal (Table 1 ) and the echocardiogram showed asymmetric septal hypertrophy without outflow obstruction.
There was also a high frequency of sudden unexpected deaths in the family. Two brothers (II-I and II-2) died suddenly at the age of 22 and 11 years, respectively, one of them while playing in the schoolyard. Their sister (II-4) died suddenly at the age of 40 years. She had a systolic cardiac murmur but no symptoms of heart disease. In generation I, I-6 died suddenly at the age of 45 years, and an echocardiographic study of his son showed signs of hypertrophic cardiomyopathy. Sudden death is common in families with hypertrophic cardiomyopathy, probably as a result of ventricular arrhythmias or acute haemodynamic changes. It is likely that the three siblings in generation II and their uncle (I-6) died of a cardiac arrhythmia, and we assume that they all had hypertrophic cardiomyopathy. The distribution of affected family members in generations I and II is compatible with autosomal dominant inheritance. We examined the three children of 14 and three of the five children of 1-6. All were symptom free. In both sibships (not shown on the pedigree) a son with definite asymmetric septal hypertrophy was found. This father to son transmission of the trait excluded X linked inheritance but was consistent with the postulated autosomal dominant mode of inheritance.
Kishimoto et al suggested that a gene locus for hypertrophic cardiomyopathy may be located on chromosome number 6 within mapable distance of the HLA complex in some families.6 Table 2 outlines the distribution of HLA haplotypes in some family members. Table 2 also indicates whether the two traits were inherited together as would have been expected if there were close genetic linkage. If the gene for hypertrophic cardiomyopathy is located on chromosome number 6, very close to the HLA complex, a particular HLA haplotype should consistently be found together with the gene for hypertrophic cardiomyopathy in a given family. The further apart on a chromosome two traits are located, the more frequently they will tend to separate during the formation of sex cells. Genes far apart on the same chromosome or situated on different chromosomes segregate independently and with equal frequency to the offspring.
In this family, eleven people may be informative (Table 2 ). Because the observed distribution (three recombinants, eight non-recombinants) or a more skewed distribution would occur by chance in 11 3% of such sets of observations this distribution may have arisen by chance. Thus, HLA typing in this family was not useful for the identification of presymptomatic gene carriers of hypertrophic cardiomyopathy. Loose genetic linkage between the two traits, however, cannot yet be excluded. In this family more information may be gained by extending the HLA typing to other family members (for example to III-14, descendants of 1-3, I-4, I-5, and I-6) and by including in the analysis other genetic chromosome number 6 markers outside the HLA complex. The distribution of HLA haplotypes among the siblings of I-2 could then be clarified, and the assumed crossover events in the vicinity of the HLA complex on chromosome number 6 (sex cells from 1-2 to II-16 and II-19) may be corroborated. Formal linkage analysis will be performed in this family when such information is available.
A high frequency of hypertrophic cardiomyopathy would be expected in generations III and IV, but only a 16 Data obtained by infusion of noradrenaline in dogs raise the possibility that the interventricular septum is more sensitive to beta adrenergic stimulation than either the right ventricle or the free wall of the left ventricle. '3 This suggests that increased sympathetic activity or increased sensitivity to catecholamines are possible mechanisms for the development of hypertrophic cardiomyopathy in the human heart. Studies by Yamori et al suggested that the beta adrenergic effects of noradrenaline were more potent than its alpha effects in inducing cardiac hypertrophy. 4 This may explain the beneficial haemodynamic effect of beta blockers in patients with hypertrophic cardiomyopathy. In the present family three brothers (II-3, II-1l, II-20) in generation II had evidence of left ventricular outflow obstruction. They were all examined by cardiac catheterisation and there was a substantial reduction in the peak systolic gradient after administration of propranolol.
Echocardiography offers a unique method of diagnosing patients with established hypertrophic cardiomyopathy. The severity of myocardial disease may be assessed and future management guided. This method, however, has not been useful in identifying young patients at risk for developing this disease. In the present family, only three family members (II-22, III-14, and III-23) and the sons of I-4 and I-6 were diagnosed by echocardiography as having hypertrophic cardiomyopathy without clinical symptoms of cardiac disease. Because there is evidence for an autosomal dominant mode of inheritance of the disease in this family, we expect that many members of the two younger generations will develop signs of the disease as adults. Longitudinal echocardiographic studies combined with functional assessments may be of some value in increasing the diagnostic rate in these younger age groups. No other existing methods are likely to be more useful in the diagnostic evaluation of hypertrophic cardiomyopathy.
